Consistent with the hypothesis that increased MEG3 expression in MS-infected cells leads to decreased TGF-β levels, we found TGF-β to be significantly downregulated in MS but not in MAH-infected cells. This evidence concerns the gene MEG3 and myeloid sarcoma.